Tafluprost/Timolol Maleate

他氟前列腺素/马来酸噻吗洛尔

Report date: 2025/03/31 15:27:02

Base Information

Drug NameTafluprost/Timolol Maleate
Drug Alias Name多佐噻吗Tafluprost/Timolol噻吗洛尔/他氟前列腺素Timolol Maleate and Tafluprost马来酸噻吗洛尔/他氟前列腺素 +[15] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta adrenergic receptors antagonistsProstanoid FP receptor agonists
TargetsProstanoid FP receptorBeta adrenergic receptors
Therapy Area/IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Global Approved IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Approved Indications in ChinaGlaucoma, Open-AngleOcular Hypertension
Original Approved Country/TerritoryJapan
Original Approved Date2013/01/01
Country/TerritoryHungaryFinlandMainland China +[4] 
CombinationsYes TafluprostTimolol Maleate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanten
China Registration ClassN/A

Develop Information

Active CompaniesAkornSanten OySanten
Inactive CompaniesLaboratoires Merck Sharp & Dohme-ChibretSanten Pharmaceutical Co LtdLaboratoire Unither +[5] 
Active IndicationsGlaucoma, Open-AngleGlaucomaOcular Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeS01ED51
Related LinksKEGG